These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14729444)

  • 1. Nefazodone-associated torsade de pointes.
    Siddiqui MA; Khan IA
    Int J Cardiol; 2004 Jan; 93(1):85-6. PubMed ID: 14729444
    [No Abstract]   [Full Text] [Related]  

  • 2. Torsade de pointes after ziprasidone overdose with coingestants.
    Alipour A; Cruz R; Lott RS
    J Clin Psychopharmacol; 2010 Feb; 30(1):76-7. PubMed ID: 20075653
    [No Abstract]   [Full Text] [Related]  

  • 3. [QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
    Züchner H
    Dtsch Med Wochenschr; 2002 May; 127(18):983-4. PubMed ID: 11987023
    [No Abstract]   [Full Text] [Related]  

  • 4. [Citalopram and Torsades de Pointes. A case report].
    Meuleman C; Jourdain P; Bellorini M; Sadeg N; Loiret J; Guillard N; Thebault B; Funck F
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1021-4. PubMed ID: 11603066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
    de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G
    Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606
    [No Abstract]   [Full Text] [Related]  

  • 6. Escitalopram: torsades de pointes.
    Prescrire Int; 2012 May; 21(127):130. PubMed ID: 22844685
    [No Abstract]   [Full Text] [Related]  

  • 7. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nefazodone-induced mania.
    Dubin H; Spier S; Giannandrea P
    Am J Psychiatry; 1997 Apr; 154(4):578-9. PubMed ID: 9090352
    [No Abstract]   [Full Text] [Related]  

  • 9. Nefazodone and visual side effects.
    Schwartz K
    Am J Psychiatry; 1997 Jul; 154(7):1038. PubMed ID: 9210763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Torsade de pointes after poisoning with fluoxetine alone].
    Lherm T; Lottin F; Larbi D; Bray M; Legall C; Caen D
    Presse Med; 2000 Feb; 29(6):306-7. PubMed ID: 10719447
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible penile priapism associated with nefazodone.
    Toofanny N; Maddens ME
    J Am Geriatr Soc; 2002 Sep; 50(9):1610-1. PubMed ID: 12383175
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute liver failure after treatment with nefazodone.
    Lucena MI; Andrade RJ; Gomez-Outes A; Rubio M; Cabello MR
    Dig Dis Sci; 1999 Dec; 44(12):2577-9. PubMed ID: 10630516
    [No Abstract]   [Full Text] [Related]  

  • 13. Nefazodone-induced spontaneous ejaculation.
    Micheal A; Ramana R
    Br J Psychiatry; 1996 Nov; 169(5):672-3. PubMed ID: 8932914
    [No Abstract]   [Full Text] [Related]  

  • 14. Nefazodone-associated subjective complaints of burning sensations.
    Lerner V; Matar MA; Polyakova I
    J Clin Psychiatry; 2000 Mar; 61(3):216-7. PubMed ID: 10817110
    [No Abstract]   [Full Text] [Related]  

  • 15. Nefazodone-induced clitoral priapism.
    Brodie-Meijer CC; Diemont WL; Buijs PJ
    Int Clin Psychopharmacol; 1999 Jul; 14(4):257-8. PubMed ID: 10468320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent interaction between nefazodone and cyclosporine.
    Helms-Smith KM; Curtis SL; Hatton RC
    Ann Intern Med; 1996 Sep; 125(5):424. PubMed ID: 8702104
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of obsessive symptoms during nefazodone treatment.
    Sofuoglu M; Debattista C
    Am J Psychiatry; 1996 Apr; 153(4):577-8. PubMed ID: 8599413
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic effects of nefazodone.
    Brazelton T; Blanc PD; Olson KR
    Ann Emerg Med; 1997 Oct; 30(4):550-1. PubMed ID: 9326873
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual "trails" with nefazodone treatment.
    Kraus RP
    Am J Psychiatry; 1996 Oct; 153(10):1365-6. PubMed ID: 8831452
    [No Abstract]   [Full Text] [Related]  

  • 20. Nefazodone and neurotoxicity.
    Yong JN
    J Clin Psychiatry; 1997 Aug; 58(8):365. PubMed ID: 9515979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.